PRESS-RELEASE ·Filed Jul 22, 2026
Press release: earnings
Actionable Insight • Neutral
This is a routine earnings date announcement with no new financial information. Monitor the Q2 2026 earnings release on August 4, 2026 for actual results and guidance.
Latest settled — T+20d
PCRX ▼ -4.81% at T+20d
NEUTRAL call ✗ call lost -4.81% · α vs SPY -7.70% · entry $25.59 → $24.36
Latest observation: T+49 +6.75% FF3 residual α
T+1d
+1.33%
call +1.33% · α +2.56%
$25.93
settled 2mo ago
T+5d
+3.17%
call +3.17% · α +5.57%
$26.40
settled 2mo ago
T+20d
-4.81%
call -4.81% · α -7.70%
$24.36
settled 6w ago
T+60d
—
call — · α —
—
in 13d
Price Chart
Loading chart...
Executive Summary
Pacira BioSciences announced it will report Q2 2026 financial results after market close on August 4, 2026, followed by a conference call. No financial data or guidance was provided in this filing.
Key Facts
- Q2 2026 earnings release scheduled for August 4, 2026 after market close
- Conference call at 4:30 p.m. ET on August 4, 2026
- No preliminary financial results or guidance disclosed
Financial Impact
No financial impact — filing is a routine earnings date announcement
Risk Factors
- No risks identified from this filing
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (12 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3331269 |
16 reports for PCRX
100% Hit rate best @ T+60▲ +6.07%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | Press Release | $25.58 $26.60 | ▲ +3.99% | ▲ +3.39% | $25.21 (−1.45%) |
Jul 22, 2026 10w ago | Press Release | $25.59 $24.36 | ▼ −4.81% | ▼ −7.70% | $25.21 (−1.48%) |
Jun 30, 2026 13w ago | 8-K | $25.37 $26.47 | ▲ +4.34% | ▲ +5.36% | $25.21 (−0.63%) |
Jun 13, 2026 15w ago | Insider Cluster | $22.74 $25.54 | ▲ +12.31% | ▲ +13.06% | $25.21 (+10.86%) |
Jun 4, 2026 17w ago | DEFA14A | $22.75 $25.59 | ▲ +12.48% | ▲ +10.62% | $25.21 (+10.81%) |
Jun 4, 2026 17w ago | 144 | $22.67 $25.39 | ▲ +12.00% | ▲ +13.37% | $25.21 (+11.20%) |
Jun 1, 2026 17w ago | DEFA14A | $22.25 $25.03 | ▲ +12.49% | ▲ +14.06% | $25.21 (+13.30%) |
May 27, 2026 18w ago | DEFA14A | $23.68 $25.24 | ▲ +6.59% | ▲ +9.73% | $25.21 (+6.46%) |
May 26, 2026 18w ago | DEFA14A | $24.04 $24.37 | ▲ +1.37% | ▲ +3.27% | $25.21 (+4.87%) |
May 20, 2026 19w ago | DEFA14A | $23.48 $22.72 | ▼ −3.24% | ▼ −3.57% | $25.21 (+7.37%) |
Showing 10 of 16
US Market Status
Market Closed — Opens Mon (65h 4m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access